Valuation: China SXT Pharmaceuticals, Inc.

Market Cap 39.64K 35.92K 33.23K 29.98K 56.5K 3.74M 58.49K 399K 158K 2M 149K 146K 6.34M P/E 2025 *
-
P/E 2026 -
Enterprise Value -27.16M -24.61M -22.77M -20.54M -38.71M -2.56B -40.07M -273M -108M -1.37B -102M -99.76M -4.34B EV / Sales 2025
9.01x
EV / Sales 2026 -22.6x
Free-Float
97.74%
Yield 2025 *
-
Yield 2026 -
1 day-0.33%
1 week-6.53%
Current month-10.84%
1 month-55.42%
3 months-99.23%
6 months-99.98%
Current year-100.00%
1 week 2.73
Extreme 2.73
3.44
1 month 2.71
Extreme 2.71
12.27
Current year 2.71
Extreme 2.71
8,376,215.05
1 year 2.71
Extreme 2.71
8,376,215.05
3 years 2.71
Extreme 2.71
61,324,376.2
5 years 2.71
Extreme 2.71
4,399,995,000
10 years 2.71
Extreme 2.71
10,000,000,000
Manager TitleAgeSince
Chief Executive Officer - 20/01/2025
Chief Executive Officer 34 04/07/2017
Director of Finance/CFO 49 31/01/2022
Director TitleAgeSince
Chairman 34 04/07/2017
Director/Board Member 49 31/12/2018
Director/Board Member 57 22/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.67%-6.53%-100.00%-100.00% 39.64K
+1.10%+3.33%+42.79%+147.80% 1,286B
+0.40%+2.12%+44.34%+91.93% 688B
+1.13%+1.76%+27.55%+115.84% 521B
+1.27%+2.09%+42.58%+72.89% 386B
+0.19%-0.56%+59.30%+45.04% 364B
+1.44%+2.34%+29.12%+64.10% 302B
+1.00%+0.48%+3.99%+39.03% 287B
+1.20%+1.15%+37.72%+74.94% 252B
+1.42%+0.60%+37.26%+128.57% 208B
Average +0.81%+2.48%+22.47%+68.01% 429B
Weighted average by Cap. +0.94%+3.23%+38.45%+101.17%

Financials

2025 2026
Net sales 1.74M 1.58M 1.46M 1.32M 2.48M 164M 2.57M 17.53M 6.95M 87.68M 6.53M 6.39M 278M 1.14M 1.03M 954K 861K 1.62M 107M 1.68M 11.46M 4.54M 57.32M 4.27M 4.18M 182M
Net income -3.3M -2.99M -2.77M -2.5M -4.71M -311M -4.87M -33.26M -13.19M -166M -12.4M -12.13M -528M -6.21M -5.62M -5.2M -4.69M -8.84M -585M -9.15M -62.48M -24.77M -313M -23.29M -22.79M -992M
Net Debt -17.25M -15.63M -14.46M -13.05M -24.59M -1.63B -25.45M -174M -68.88M -869M -64.75M -63.37M -2.76B -27.2M -24.65M -22.8M -20.57M -38.76M -2.56B -40.13M -274M -109M -1.37B -102M -99.91M -4.35B
Projected Income Statement - Annual - China SXT Pharmaceuticals, Inc.
Logo China SXT Pharmaceuticals, Inc.
China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.
Employees
-
Date Price Change Volume
16/11/26 US$2.925 -2.50% 23,791
13/11/26 US$3.000 +9.89% 228,098
12/11/26 US$2.730 -3.53% 51,476
11/11/26 US$2.830 -1.74% 51,457
10/11/26 US$2.880 -7.10% 93,726
  1. Stock Market
  2. Stocks
  3. SXTC Stock